- Home
- NTRS vs WAT Comparison
NTRS vs WAT Comparison
Compare NTRS & WAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NTRS | WAT |
|---|---|---|
| Founded | 1889 | 1958 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.5B | 22.5B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | NTRS | WAT |
|---|---|---|
| Price | $152.99 | $398.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 16 |
| Target Price | $131.00 | ★ $390.67 |
| AVG Volume (30 Days) | ★ 792.1K | 410.0K |
| Earning Date | 01-22-2026 | 02-12-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | ★ 7.22 | 3.82 |
| EPS | 8.58 | ★ 10.88 |
| Revenue | ★ $7,932,900,000.00 | $3,105,638,000.00 |
| Revenue This Year | N/A | $7.93 |
| Revenue Next Year | $4.59 | $6.30 |
| P/E Ratio | ★ $16.84 | $36.48 |
| Revenue Growth | 0.96 | ★ 6.90 |
| 52 Week Low | $81.62 | $275.05 |
| 52 Week High | $148.98 | $423.56 |
Technical Indicators
Market Signals| Indicator | NTRS | WAT |
|---|---|---|
| Relative Strength Index (RSI) | 71.89 | 58.93 |
| Support Level | $140.39 | $376.48 |
| Resistance Level | $148.98 | $401.74 |
| Average True Range (ATR) | 3.58 | 10.19 |
| MACD | 0.19 | -0.01 |
| Stochastic Oscillator | 75.19 | 72.69 |
Price Performance
Historical ComparisonAbout NTRS Northern Trust Corporation
Northern Trust is a leading provider of wealth management, asset servicing, asset management, and banking to corporations, institutions, affluent families, and individuals. Founded in Chicago in 1889, Northern Trust has offices in 20 states and Washington, D.C. as well as 23 locations in Canada, Europe, the Middle East, and Asia-Pacific. As of December 2024, Northern Trust had assets under custody or administration of $16.8 trillion and assets under management of $1.6 trillion.
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.